Clinical Trials Directory

Trials / Unknown

UnknownNCT03098758

Molecular Analysis in Peritoneal Washing Citology for Locally Advanced Gastric Cancer

Pilot Study of Comparative Molecular Analysis CK20, CEA and BER-EP4 in Peritoneal Washing Citology for Locally Advanced Gastric Cancer and Their Ability to Predict Peritoneal Dissemination

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Corporacion Parc Tauli · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Gastric carcinoma is a disease with a high mortality. Peritoneal washing cytology has a recognized prognostic utility. However sensibility of this study is not appropriate. Studies with PCR (polymerase chain retrotranscription) can increase sensibility and accurate staging information. Objective: To analyze the sensibility and specificity of the expression of CK20, CEA and Ber-EP4 with PCR technique in peritoneal washings of advanced gastric carcinoma without clinical evidence of peritoneal carcinomatosis. Methodology: Retrotranscription analysis (RT-PCR) and quantitative PCR (qPCR) of CK20, CEA and Ber-EP4 in peritoneal washing. Test the feasibility of qPCR with this new marker (Ber-EP4). Comparison of the results with data obtained with conventional cytology. Study of peritoneal recurrence.

Conditions

Timeline

Start date
2017-05-08
Primary completion
2020-04-01
Completion
2020-04-01
First posted
2017-04-04
Last updated
2019-07-24

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03098758. Inclusion in this directory is not an endorsement.

Molecular Analysis in Peritoneal Washing Citology for Locally Advanced Gastric Cancer (NCT03098758) · Clinical Trials Directory